Leveraging CTCsfor Innovative Delivery of Factor VIII

Excellence in Hemophilia Care Provided By Baxter

pFVIII

rFVIII

rFVIII PFM

1966

ɰ Billion Units Administered

2002

1992

FVIII First Introduced

Submitted for Regulatory Approval

pFVIII

1983

Heat Treated

pFVIII

1988

Antibody Purified & Enhanced Viral Inactivation

Previous slide

Next slide

Back to first slide

View graphic version